AurorA-TT Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 5


  • Investments
  • 2

  • Portfolio
  • 1

AurorA-TT General Information


Founded in 2017, AurorA-TT is a venture capital firm based in Milan, Italy. The firm prefers to invest in early-stage Italian companies operating in the biotech and pharma sectors. The firm projects to bridge the gap between basic research and industrial drug development with a focus on oncology, immunology, rare diseases, infectious diseases, cardiovascular diseases, and central nervous system diseases.

Contact Information

Year Founded
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Primary Office
  • Via Pontaccio, 14
  • 20121 Milan
  • Italy
+39 02 0000 0000

AurorA-TT Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Peptomyc 16-Dec-2020 Later Stage VC 00.000 Drug Discovery Clinical Trials - Phase 2 00000 00000 00
Peptomyc 29-May-2020 00000 00000 00.000 Drug Discovery Clinical Trials - Phase 2
To view AurorA-TT’s complete investments history, request access »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AurorA-TT Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

AurorA-TT Team (5)

Name Title Deals Funds Boards Office
Edoardo Negroni Co-Founder & Managing Partner 0 Milan, Italy
Gabriele Campi Ph.D Co-Founder & Managing Partner Milan, Italy
Pierluigi Paracchi Co-Founder & Managing Partner 0 Milan, Italy
Guido Guidi MD Co-Founder, Managing Partner and Chairman 0 0 Milan, Italy
Paolo Rizzardi MD Co-Founder & Managing Partner 0 Milan, Italy
To view AurorA-TT’s complete team members history, request access »